Cargando…

Lung Adenocarcinoma Size Decrease after SARS-CoV-2 Vaccination during Long-Term Pembrolizumab Treatment: A Case Report

A man in his late 40s was diagnosed with clinical stage 4B lung adenocarcinoma with a PD-L1 tumor proportion score of 100% and high tumor mutational burden. A partial response was achieved after administration of pembrolizumab. The patient received two doses of a SARS-CoV-2 vaccine (BNT162b2) after...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujii, Koki, Fukuda, Kensuke, Kawakami, Masanori, Mitani, Akihisa, Tanaka, Goh, Kage, Hidenori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601772/ https://www.ncbi.nlm.nih.gov/pubmed/37900823 http://dx.doi.org/10.1159/000533705

Ejemplares similares

Acute Arterial Thrombosis during Postoperative Adjuvant Cisplatin-based Chemotherapy for Completely Resected Lung Adenocarcinoma
por: Sato, Chihiro, et al.
Publicado: (2017)

Multiple Brain Metastases in a Patient with ROS1 Fusion-Positive Lung Adenocarcinoma as a Disease Flare due to Crizotinib Cessation Caused by Disseminated Aseptic Inflammation from Crizotinib-Associated Renal Cysts: A Case Report
por: Amano, Yosuke, et al.
Publicado: (2022)

Pulmonary carcinoid tumour with remarkably high levels of pro-gastrin-releasing peptide: A case report
por: Nakagawa, Natsuki, et al.
Publicado: (2023)

Multiple cerebral infarctions in ROS1‐rearranged lung adenocarcinoma
por: Ikushima, Hiroaki, et al.
Publicado: (2021)

Hyperprogressive disease after treatment with pembrolizumab in lung adenocarcinoma: An autopsy case study
por: Tanaka, Yuko, et al.
Publicado: (2019)

Lung Adenocarcinoma with Paraneoplastic Hyper-Eosinophilia Not Responding To Pembrolizumab
por: Wehbe, Hisham, et al.
Publicado: (2021)

Pembrolizumab-Induced Delayed-Onset Hepatitis
por: Kanaoka, Kensuke, et al.
Publicado: (2020)

Intralymphatic histiocytosis in a patient with lung adenocarcinoma treated with pembrolizumab: a case report
por: Sugano, Teppei, et al.
Publicado: (2019)

Pancreatic metastasis from lung adenocarcinoma
por: Aoyama, Naoki, et al.
Publicado: (2023)

Pembrolizumab-Induced Seronegative Arthritis and Fasciitis in a Patient with Lung Adenocarcinoma
por: Kobak, Senol
Publicado: (2019)

Cholestatic Liver Injury Induced by Pembrolizumab in a Patient with Lung Adenocarcinoma
por: Kurokawa, Kana, et al.
Publicado: (2019)

Hemophagocytic Lymphohistiocytosis in a Patient with Rheumatoid Arthritis on Pembrolizumab for Lung Adenocarcinoma
por: Akagi, Yu, et al.
Publicado: (2020)

Retrobulbar Optic Neuritis Induced by Pembrolizumab in a Patient with Lung Adenocarcinoma
por: Kawakado, Keita, et al.
Publicado: (2021)

Survival Benefit of Pembrolizumab for Patients With Pancreatic Adenocarcinoma: A Case Series
por: Zhao, Li, et al.
Publicado: (2022)

Two Cases of Pembrolizumab-Induced Secondary Adrenal Insufficiency
por: Kanzaki, Akinori, et al.
Publicado: (2021)

KRAS4A and KRAS4B in liquid biopsy of metastatic lung adenocarcinoma patients treated with Pembrolizumab or chemotherapy plus Pembrolizumab
por: Chiari, Rita, et al.
Publicado: (2023)

Pembrolizumab
por: Khoja, Leila, et al.
Publicado: (2015)

Pembrolizumab monotherapy versus pembrolizumab plus chemotherapy in patients with non‐small‐cell lung cancer: A multicenter retrospective trial
por: Matsumoto, Hiromi, et al.
Publicado: (2021)

Hyperprogression in PDL1 Expressive, Recurrent Gastroesophageal-junction Adenocarcinoma After Pembrolizumab
por: Sama, Shashank, et al.
Publicado: (2019)

Refractory Bullous Pemphigoid in a Patient with Metastatic Lung Adenocarcinoma Treated with Pembrolizumab
por: Cardona, Andrés F., et al.
Publicado: (2021)

Pneumocystis pneumonia in patient with lung adenocarcinoma: early side effects from pembrolizumab
por: Hiba, Zahi, et al.
Publicado: (2022)

Beyond the Expectation: Pembrolizumab-Associated Tumor Lysis Syndrome in Metastatic Gastric Adenocarcinoma
por: Battah, Arwa, et al.
Publicado: (2023)

Pembrolizumab-induced Myasthenia Gravis Relapse after Immunosuppressive Therapy
por: Oshima, Yuki, et al.
Publicado: (2022)

Association between Diabetic Peripheral Neuropathy as Measured Using a Point-of-Care Sural Nerve Conduction Device and Urinary Albumin Excretion in Patients with Type 2 Diabetes
por: Fukuda, Tatsuya, et al.
Publicado: (2023)

Willingness of Patients With Knee Osteoarthritis to Use Telemedicine Amid Sars-CoV-2 Outbreak
por: Takahashi, Tsuneari, et al.
Publicado: (2020)

Pembrolizumab or pembrolizumab plus chemotherapy versus standard of care chemotherapy in patients with advanced gastric or gastroesophageal junction adenocarcinoma: Asian subgroup analysis of KEYNOTE-062
por: Satake, Hironaga, et al.
Publicado: (2022)

Renal Effects after Pembrolizumab Treatment for Non-small Cell Lung Carcinoma
por: Oki, Rikako, et al.
Publicado: (2019)

Pembrolizumab-related Immune Thrombocytopenia in a Patient with Lung Adenocarcinoma Treated by Radiotherapy: Potential Immune-related Adverse Event Elicited by Radiation Therapy
por: Tamanoi, Daisuke, et al.
Publicado: (2021)

A Rare Cause of Gastrointestinal Bleeding after Appendectomy
por: Iimori, Kei, et al.
Publicado: (2022)

The role of pembrolizumab in the treatment of PD-L1 expressing gastric and gastroesophageal junction adenocarcinoma
por: Brar, Gagandeep, et al.
Publicado: (2019)

Monitoring antibody binding to T cells in a pembrolizumab‐treated patient with lung adenocarcinoma on hemodialysis
por: Osa, Akio, et al.
Publicado: (2019)

Perforation of small intestinal metastasis of lung adenocarcinoma treated with pembrolizumab: a case report
por: Sato, Shoki, et al.
Publicado: (2019)

Response to pembrolizumab in a patient with primary lung adenocarcinoma originated from indium lung
por: Sekine, Yasuharu, et al.
Publicado: (2021)

Inflammatory Thoracic Aortic Aneurysm in a Patient with Advanced Lung Adenocarcinoma Treated with Pembrolizumab
por: Ninomiya, Ryusuke, et al.
Publicado: (2022)

Treatment of gastric hepatoid adenocarcinoma with pembrolizumab and bevacizumab combination chemotherapy: A case report
por: Liu, Mei, et al.
Publicado: (2022)

The role of the SWI/SNF chromatin remodeling complex in pancreatic ductal adenocarcinoma
por: Tsuda, Motoyuki, et al.
Publicado: (2020)

Changes in diagnostic usefulness of the JRS scoring system in COVID-19 pneumonia by SARS-CoV-2 vaccination
por: Miyashita, Naoyuki, et al.
Publicado: (2022)

Impact of radiotherapy to the primary tumor on the efficacy of pembrolizumab for patients with advanced urothelial cancer: A preliminary study
por: Fukushima, Hiroshi, et al.
Publicado: (2020)

Population Pharmacokinetic/Pharmacodynamic Modeling of Tumor Size Dynamics in Pembrolizumab‐Treated Advanced Melanoma
por: Chatterjee, MS, et al.
Publicado: (2016)

Pembrolizumab for all
por: Kim, Myung S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rngvbkhrc69vre2415h0e18g2k